Are you Dr. LoCicero?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 75 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
725 Jesse Jewell Pkwy SE
Gainesville, GA 30501Phone+1 770-297-5700Fax+1 770-718-1877
Summary
- Dr. Richard LoCicero, MD is a hematologist in Gainesville, Georgia. He is currently licensed to practice medicine in Georgia, New York, and Tennessee. He is affiliated with Northeast Georgia Medical Center, Northeast Georgia Medical Center Braselton, and Northeast Georgia Medical Center Barrow.
Education & Training
- San Antonio Uniformed Services Health Education ConsortiumFellowship, Hematology and Medical Oncology, 1994 - 1997
- Keesler Medical CenterResidency, Internal Medicine, 1991 - 1994
- Vanderbilt University School of MedicineClass of 1991
Certifications & Licensure
- GA State Medical License 2000 - 2025
- NY State Medical License 2015 - 2018
- TN State Medical License 1993 - 2001
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Hospice and Palliative Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Clinical Trials
- Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Start of enrollment: 2005 Nov 01
- Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer Start of enrollment: 2006 Sep 26
- Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery Start of enrollment: 2007 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- 12 citationsA Phase II Study of FOLFOXIRI Plus Panitumumab Followed by Evaluation for Resection in Patients With Metastatic KRAS Wild-Type Colorectal Cancer With Liver Metastases ...Johanna C. Bendell, Ahmed Zakari, James D. Peyton, Ralph V. Boccia, Mark Moskowitz
The Oncologist. 2016-03-01 - 44 citationsPhase II study of neoadjuvant weekly nab-paclitaxel and carboplatin, with bevacizumab and trastuzumab, as treatment for women with locally advanced HER2+ breast cancer.Denise A. Yardley, Eric Raefsky, Raul Castillo, Anup Lahiry, Richard LoCicero
Clinical Breast Cancer. 2011-10-01 - 10 citationsEqual Effectiveness of Very—Low-Intensity Anticoagulation and Standard Low-Intensity Anticoagulation: A Pilot studyKevin Klein, Donald Berdeaux, James Milhollen, John Hilden, Nancy Obernuefemann
Southern Medical Journal. 1995-11-01
Professional Memberships
- Member